Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Assault On Drug Marketing Tactics Becomes Drug-Specific On Capitol Hill

Executive Summary

Pharmaceutical firms avoided a moratorium on direct-to-consumer television ads in the FDA Amendments Act, but that victory seems of little comfort now as Congress undertakes a wide-ranging probe of industry marketing practices
Advertisement

Related Content

Academic Detailing Bill Could Be Interim Step To Comparative Effectiveness
Will Schering-Plough’s Vytorin Headache Prove Contagious?
Schering’s Zetia Promotion To Physicians Draws Inquiry From Sen. Kohl
Congress Spars With FDA On Budget Figures And Scientific Readiness
FDA To Review Vytorin Data: ENHANCEd Label To Follow?
FDA To Review Vytorin Data: ENHANCEd Label To Follow?
Vytorin Gets Medical Group Support, Congressional Query On ENHANCE
Vytorin Gets Medical Group Support, Congressional Query On ENHANCE
DTC User Fee Program’s Demise Leaves Advertisers Bobbing In Its Wake
Can ENHANCE Diminish Vytorin? Schering, Merck Minimize Trial’s Importance
Advertisement
UsernamePublicRestriction

Register

PS049223

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel